Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. (ATNM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ATNM · as of Jun 8, 2026
Key Statistics
Explore Actinium Pharmaceuticals, Inc. Data
atnm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 100.0%
The ATNM analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $11.07, representing +944.34% upside from the current price of $1.06.
Competitors & Peers
atnm competitorsATNM
ANVS
FGEN
KZR
LVTX
OKURStock Performance
Full HistoryAbout Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing and commercializing treatments, primarily focusing on those for bone marrow transplant (BMT) or other …
what is actinium pharmaceuticals, inc. · atnm stock overview · actinium pharmaceuticals, inc. company profile · who is actinium pharmaceuticals, inc. ceo · atnm AMEX · actinium pharmaceuticals, inc. headquarters · actinium pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Actinium Pharmaceuticals, Inc. (ATNM) is a Healthcare company in the Biotechnology industry, listed on AMEX since Dec 27, 2012. As of the latest trading session, ATNM stock price is $1.06, with a market capitalization of $33.3M. The stock has returned -45.36% over the past 12 months and -22.06% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Actinium Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $11.07. In fiscal year 2025, Actinium Pharmaceuticals, Inc. reported revenue of $90000.00 and net income of -$33.9M. For detailed data — including Actinium Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Actinium Pharmaceuticals, Inc. (ATNM) stock price is $1.06. The stock is traded on AMEX under the ticker symbol ATNM. The 52-week range is $0.95 – $1.95.